BIO-Y A/S: Financial statements 2023
CVR: 25507800
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIO-Y A/S (CVR 25507800) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -40,037 and a net result of DKK -782,767 compared with DKK -1,389,757 the year before. Equity in the 2023 report amounted to DKK -2,703,973. The company had 1 employee in the financial year.
- Gross Profit
- DKK -40,037
- Profit/Loss
- DKK -782,767
- Equity
- DKK -2,703,973
- Total Assets
- DKK 3,227,557
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -40K | -783K | -2.7M | 1 |
| 2022 | - | -51K | -1.4M | -4.5M | 1 |
| 2021 | - | -39K | -502K | -4.2M | 1 |
| 2020 | - | -69K | -696K | -3.7M | 1 |
| 2019 | - | 1.3M | 441K | -3M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 10, 2023, Holdingselskabet af 26. oktober 2023 ApS is registered as an owner of BIO-Y A/S with an ownership share of 50%.
BIO-Y A/S has published its annual report for 2022. Gross profit came to DKK -51,214, and the net result was DKK -1,389,757.
About BIO-Y A/S
BIO-Y A/S is a Danish company of the type Aktieselskab based in Helsingør, founded in 2000. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GENOMICS A/S and SCSK 3327 A/S. The company is owned by Holdingselskabet af 26. oktober 2023 ApS and Hamlet Investments Limited. The company has 1 employee (2026). In 2024, the company reported a gross profit of DKK -43,680 and a net result of DKK -1,013,053 compared with DKK -782,767 the year before. Equity in the 2024 report amounted to DKK -3,717,025.